ERGOMINI ET ERGONIC. ATELIERS FLEXIBLES ET MICROCABLAGESGARDET P.1981; CONGRES AUTOMATIQUE/1981/NANTES; FRA; PARIS: AFCET; DA. 1981; PP. 359-363Conference Paper

CONTRIBUTION A L'ETUDE DES ANESTHESIES EN PEDODONTIE.GARDET P.1977; ; S.L.; DA. 1977; PP. 1-61; BIBL. 3 P.; (THESE DOCT. CHIR. DENT.; TOULOUSE III)Thesis

DISPARITION DE LA METAPLASIE MYELOIDE HEPATIQUE APRES RADIOTHERAPIE SPLENIQUE D'UNE SPLENOMEGALIE MYELOIDECHARBORD P; GARDET P; CAILLOU B et al.1978; NOUV. REV. FR. HEMATOL.; FRA; DA. 1978; VOL. 20; NO 3; PP. 435-442; ABS. ENG; BIBL. 14 REF.Article

Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinomaSCHLUMBERGER, M; TUBIANA, M; DE VATHAIRE, F et al.The Journal of clinical endocrinology and metabolism. 1986, Vol 63, Num 4, pp 960-967, issn 0021-972XArticle

Long-term results and prognostic factors in patients with differentiated thyroid carcinomaTUBIANA, M; SCHLUMBERGER, M; ROUGIER, P et al.Cancer. 1985, Vol 55, Num 4, pp 794-804, issn 0008-543XArticle

Chimiothérapie des cancers médullaires de la thyroïde: essais phase II avec adriamycine et cis-platinum administrés en monochimiothérapie = Chemotherapy for medullary thyroid carcinoma (phase I trial of monochemotherapy with adriamycin and cis-platinum)DROZ, J.-P; ROUGIER, P; GODDEFROY, V et al.Bulletin du cancer. 1984, Vol 71, Num 3, pp 195-199, issn 0007-4551Article

Néoplasies endocriniennes multiple type 2b: aspects cliniques, diagnostiques et thérapeutiques = Multiple endocrine neoplasia type 2b. Clinical diagnostic and therapeutical featuresGARDET, P; ROUGIER, P; NAVARRO, J et al.Bulletin du cancer. 1984, Vol 71, Num 3, pp 172-181, issn 0007-4551Article

Screening for adrenal medullary disease in patients with medullary thyroid carcinomaBONNIN, F; SCHLUMBERGER, M; GARDET, P et al.Journal of endocrinological investigation (Testo stampato). 1994, Vol 17, Num 4, pp 253-257, issn 0391-4097Article

A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patientsSCHLUMBERGER, M; FRAGU, P; GARDET, P et al.European journal of nuclear medicine. 1991, Vol 18, Num 3, pp 153-157, issn 0340-6997Article

Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinomaMANIL, L; BOUDET, F; BELLET, D et al.Cancer research (Baltimore). 1989, Vol 49, Num 19, pp 5480-5485, issn 0008-5472Article

Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysisSOBOL, H; NAROD, S. A; DUPOND, J. L et al.The New England journal of medicine. 1989, Vol 321, Num 15, pp 996-1001, issn 0028-4793Article

Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinomaBAUDIN, E; LUMBROSO, J; SCHLUMBERGER, M et al.The Journal of nuclear medicine (1978). 1996, Vol 37, Num 6, pp 912-916, issn 0161-5505Article

Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinomaABDELMOUMENE, N; SCHLUMBERGER, M; GARDET, P et al.British journal of cancer. 1994, Vol 69, Num 6, pp 1141-1144, issn 0007-0920Conference Paper

Identification and measurement of calcitonin precursors in serum of patients with malignant diseasesGHILLANI, P. P; MOTTE, P; TROALEN, F et al.Cancer research (Baltimore). 1989, Vol 49, Num 23, pp 6845-6851, issn 0008-5472Article

Les signes cliniques das cancers médullaires de la thyroïde = Clinical signs of medullary thyroid carcinomaDELISLE, M. J; GARDET, P; LAPLANCHE, A et al.Bulletin du cancer. 1984, Vol 71, Num 3, pp 165-171, issn 0007-4551Article

The use of 32 phosphorus (³²P) in the treatment of polycythemia veraPARMENTIER, C; GARDET, P.Nouvelle revue française d'hématologie. 1994, Vol 36, Num 2, pp 189-192, issn 0029-4810Conference Paper

Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinomaBEN MRAD, M. D; GARDET, P; ROCHE, A et al.Cancer. 1989, Vol 63, Num 1, pp 133-138, issn 0008-543XArticle

Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytomaNAROD, S. A; SOBOL, H; GARDET, P et al.Human genetics. 1989, Vol 83, Num 4, pp 353-358, issn 0340-6717Article

Cancers médullaires thyroïdiens: facteurs pronostiques des formes sporadiques non associées. Implications thérapeutiques = Non associated sporadic medullary thyroid carcinoma. Prognostic factors and surgical treatmentGARDET, P; ROUGIER, P; LAPLANCHE, A et al.Bulletin du cancer. 1984, Vol 71, Num 3, pp 188-191, issn 0007-4551Article

Traitement chirurgical du cancer médullaire de la thyroïde = Surgical treatment of medullary thyroid carcinomaTRAVAGLI, J.-P; GARDET, P; BLAZQUEZ, D et al.Bulletin du cancer. 1984, Vol 71, Num 3, pp 192-194, issn 0007-4551Article

Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B familiesROSSEL, M; SCHUFFENECKER, I; BILLAUD, M et al.Human genetics. 1995, Vol 95, Num 4, pp 403-406, issn 0340-6717Article

Malignant pheochromocytoma : clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastasesSCHLUMBERGER, M; GICQUEL, C; GARDET, P et al.Journal of endocrinological investigation (Testo stampato). 1992, Vol 15, Num 9, pp 631-642, issn 0391-4097Article

Quantification of intracellular calcitonin gene transcripts in human medullary thyroid carcinoma (MTC) by in situ hybridizationNOEL, M; GAVOILLE, A; LASMOLES, F et al.Journal of endocrinological investigation (Testo stampato). 1990, Vol 13, Num 7, pp 567-573, issn 0391-4097Article

Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodiesMOTTE, P; VAUZELLE, P; GARDET, P et al.Clinica chimica acta. 1988, Vol 174, Num 1, pp 35-54, issn 0009-8981Article

Cytogenetic studies on patients with medullary carcinoma of the thyroidLE CONIAT, M; VECCHIONE, D; PACOT, A et al.Cancer genetics and cytogenetics. 1987, Vol 25, Num 2, pp 303-307, issn 0165-4608Article